BARBIERI, Maria Antonietta
 Distribuzione geografica
Continente #
EU - Europa 2.195
NA - Nord America 1.714
AS - Asia 1.296
SA - Sud America 351
AF - Africa 53
OC - Oceania 6
Totale 5.615
Nazione #
US - Stati Uniti d'America 1.645
RU - Federazione Russa 1.336
SG - Singapore 555
BR - Brasile 289
CN - Cina 287
IT - Italia 201
HK - Hong Kong 151
IE - Irlanda 149
SE - Svezia 126
DE - Germania 77
VN - Vietnam 75
IN - India 68
PL - Polonia 52
FR - Francia 47
CA - Canada 39
BD - Bangladesh 35
GB - Regno Unito 35
FI - Finlandia 34
EE - Estonia 32
IQ - Iraq 22
NL - Olanda 21
AR - Argentina 17
MX - Messico 17
ZA - Sudafrica 17
JP - Giappone 14
TR - Turchia 14
ES - Italia 13
ID - Indonesia 13
UA - Ucraina 13
BE - Belgio 12
MA - Marocco 11
AT - Austria 10
CO - Colombia 10
EC - Ecuador 10
CL - Cile 9
CI - Costa d'Avorio 6
PK - Pakistan 6
VE - Venezuela 6
LT - Lituania 5
TH - Thailandia 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
EG - Egitto 4
LB - Libano 4
OM - Oman 4
PA - Panama 4
PH - Filippine 4
PY - Paraguay 4
SA - Arabia Saudita 4
TW - Taiwan 4
UY - Uruguay 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CH - Svizzera 3
CR - Costa Rica 3
DZ - Algeria 3
JO - Giordania 3
KZ - Kazakistan 3
NO - Norvegia 3
NP - Nepal 3
RO - Romania 3
RS - Serbia 3
TN - Tunisia 3
AL - Albania 2
AU - Australia 2
BO - Bolivia 2
GE - Georgia 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
LV - Lettonia 2
MY - Malesia 2
PT - Portogallo 2
SN - Senegal 2
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CD - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LY - Libia 1
MN - Mongolia 1
MU - Mauritius 1
NG - Nigeria 1
NR - Nauru 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PW - Palau 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TO - Tonga 1
TZ - Tanzania 1
Totale 5.615
Città #
Ashburn 382
Moscow 359
Singapore 345
Dallas 231
Chandler 161
Hong Kong 151
Dublin 148
San Jose 138
Beijing 90
Nyköping 65
The Dalles 56
Los Angeles 52
Messina 52
Warsaw 48
Munich 39
São Paulo 28
New York 25
Rome 25
Ho Chi Minh City 23
Hyderabad 22
Frankfurt am Main 21
Lauterbourg 21
Santa Clara 21
Turku 21
Princeton 19
Medford 18
Orem 18
Tianjin 18
Buffalo 15
Redondo Beach 15
Seattle 14
Amsterdam 13
Council Bluffs 13
Denver 13
Hanoi 13
Montreal 13
Brooklyn 12
Brussels 12
Dearborn 12
Des Moines 12
Guangzhou 12
Baghdad 11
Catania 11
Chennai 11
Belo Horizonte 10
Jacksonville 10
Stockholm 10
Tokyo 10
London 9
Paternò 9
Rio de Janeiro 9
Shanghai 9
Boston 8
Helsinki 8
Jakarta 8
Milan 8
Mumbai 8
Toronto 8
Vienna 8
Wilmington 8
Johannesburg 7
Mexico City 7
Pune 7
Salvador 7
Abidjan 6
Bremen 6
Changsha 6
Houston 6
Nuremberg 6
Santiago 6
Atlanta 5
Bari 5
Bexley 5
João Pessoa 5
Lamezia Terme 5
Manchester 5
New Delhi 5
Shenzhen 5
Boardman 4
Brno 4
Calgary 4
Campinas 4
Charlotte 4
Columbus 4
Coronel Fabriciano 4
Dong Ket 4
Hillsboro 4
Istanbul 4
Medellín 4
Miami 4
Montevideo 4
Muscat 4
Ottawa 4
Pittsburgh 4
Poplar 4
Riyadh 4
San Francisco 4
Amman 3
Baku 3
Beirut 3
Totale 3.128
Nome #
Anti-obesity drug therapy in clinical practice: Evidence of a poor prescriptive attitude 227
Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study 226
A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults. 217
Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database 197
Anticancer and anti-inflammatory properties of ganoderma lucidum extract effects on melanoma and triple-negative breast cancer treatment 195
Ototoxic adverse drug reactions: A disproportionality analysis using the Italian spontaneous reporting database 184
Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care 181
Chronic Kidney Disease Management in General Practice: A Focus on Inappropriate Drugs Prescriptions 176
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database 176
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project 169
Clinically Relevant Drug Interactions Between Statins and Antidepressants 169
Safety and tolerability of antipsychotic drugs in pediatric patients: data from an ongoing active pharmacovigilance study in Sicily 162
Pediatric adverse reactions to antiseizure medications – An analysis of data from the Italian spontaneous reporting system (2001–2019) 161
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database 152
Effectiveness and safety profile of dupilumab in chronic Rhinosinusitis with nasal polyps: real-life data in tertiary care 149
Management of High Cardiovascular Risk in Diabetic Patients: Focus on Low Density Lipoprotein Cholesterol and Appropriate Drug Use in General Practice 148
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study 145
Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients 144
Safety and Tolerability of Antipsychotic Drugs in Pediatric Patients: Data From a 1-Year Naturalistic Study 137
Clinically relevant drug interactions between newer antidepressants and oral anticoagulants 134
Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents 132
Beta-Blocker Use in Older Hospitalized Patients Affected by Heart Failure and Chronic Obstructive Pulmonary Disease: An Italian Survey From the REPOSI Register 129
Cardiovascular Adverse Drug Reactions of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for Migraine Prevention: An Analysis from the European Spontaneous Adverse Event Reporting System 125
Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database 113
Comparison Study of the Safety Profile of Olaparib Versus Niraparib: Analysis of Real-World Data from EudraVigilance 111
Management of patients with inflammatory bowel diseases: evaluating effectiveness, safety, and drug repurposing strategies 110
Dupilumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience 110
Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System 104
Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System 96
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues 90
The intertwining of healthcare-associated infections and COVID-19 in Italian intensive care units: an analysis of the SPIN-UTI project from 2006 to 2021 86
Impact of the COVID-19 Pandemic on Chronic Neurological Disorders: Focus on Patients with Dementia 83
Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database 75
Optimization of Therapy in Patients with Epilepsy and Psychiatric Comorbidities: Key Points 74
Artificial intelligence for the optimal management of community-acquired pneumonia 73
Cardiovascular Safety Profile of BRAF and MEK Inhibitors in Melanoma: FAERS Data Through a Retrospective Disproportionality Analysis (2014–2023) 72
Cenobamate: A Review of its Pharmacological Properties, Clinical Efficacy and Tolerability Profile in the Treatment of Epilepsy 70
Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting System 68
Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System 65
Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database 62
Drug Repurposing in Crohn’s Disease Using Danish Real-World Data 61
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data 53
Network Analysis and Machine Learning for Signal Detection and Prioritization Using Electronic Healthcare Records and Administrative Databases: A Proof of Concept in Drug-Induced Acute Myocardial Infarction 49
Drug Safety and Relevant Issues in the Real-World 45
Timing Matters: A Machine Learning Method for the Prioritization of Drug–Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure 45
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review 37
A newly developed method for assessing co-exposure to free dose combinations: a proof-of-concept study using antihypertensive medications in Danish registers 30
Proprotein convertase subtilisin/kexin type 9: a promising marker of cardiovascular risk in post-menopausal diabetic women in primary prevention 29
null 22
Artificial intelligence in pharmacovigilance signal management: a review of tools, implementations, research, and regulatory landscape 21
Mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience 21
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma 15
Exploring drug interactions between newer antidepressants and medications used to treat neurological disorders 9
An update on the pharmacokinetic and pharmacodynamic interactions between antidepressants and antiseizure medications 5
Factors Associated with Parental Vaccine Hesitancy in Childhood Immunization: Insights from a Cross-Sectional Survey in Southern Italy 4
Totale 5.743
Categoria #
all - tutte 17.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.920


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/2022168 5 13 0 2 10 9 8 7 0 47 5 62
2022/2023476 33 56 20 51 26 43 7 49 174 1 14 2
2023/2024185 12 16 23 13 12 33 19 8 4 25 6 14
2024/20251.143 21 17 28 72 37 54 68 188 228 121 152 157
2025/20263.613 223 177 303 261 286 612 434 486 455 231 79 66
Totale 5.743